Park et al. showed that advanced disease states of bladder cancer had higher circulating levels of osteopontin (stage T1 versus stage T2 and T2 versus T3) and were associated with a worse prognosis [6]. This evidence concerns the gene SPP1 and urinary bladder carcinoma.